9
Participants
Start Date
October 3, 2023
Primary Completion Date
August 31, 2026
Study Completion Date
August 31, 2028
AAV2-GDNF gene therapy
Bilateral image-guided infusion of AAV2-GDNF into putamen, single dose
Sham (Placebo) Surgery
Bilateral partial burr/twist holes without dural penetration
NYU Langone Health, New York
Parkinson's Disease and Movement Disorders Center of Boca Raton, Boca Raton
Vanderbilt University Medical Center, Nashville
The Ohio State University Medical Center, Columbus
Quest Research Institute, Farmington Hills
University of California Irvine, Irvine
Massachusetts General Hospital, Boston
Lead Sponsor
Brain Neurotherapy Bio, Inc.
INDUSTRY